In two experiments involving 9 GBM and 1 grade III mixed glioma specimens, PD-L1 protein was detected in all glioma samples and areas with PD-L1+-cells accounted for 50–90% of the specimens (Wintterle et al., 2003). Here, CD274 is linked to central nervous system cancer.